ABOUT US
Business Strategy
License-in
A new drug pipeline with the safety
and efficacy which are verified
by initial clinical practices
Clinic & License
Creating added values by securing global capabilities
specialized in development and organization
License-out
Creating license-out achievements targeting
global big pharmas in late phase clinical
or new drug approval
Initial funding
SAVE
Improving efficiency through specialized divisional work by field
Return on Investment
Maximizing added values